Indirect Calorimetry Usage and Effect in Ventilator-free Days and Muscle Thickness in Septic Ventilated Patients
Utilization of Indirect Calorimetry for Calculation of Nutritional Goals and Its Effect in Ventilator-free Days and Muscle Thickness in Septic Mechanically Ventilated Patients
1 other identifier
interventional
25
1 country
1
Brief Summary
Patients admitted to the ICU with diagnosis of sepsis and requiring mechanical ventilation for at least 24-hours and receiving enteral or parenteral nutrition will be prospectively randomized to one of two arms. Patients allocated to the estimated energy expenditure group will receive nutrition with caloric intake calculated based on the Penn State equation. Patients randomized to the measured group will receive nutrition with caloric intake calculated based on IC measurement present in the GE ventilator. Patients in the estimated group will have IC performed, but these data will not be used for prescription of nutrition. An equal number of beds within the ICU will be allocated to the measured group and the estimated group. The primary objective is to assess whether the utilization of indirect calorimetry for caloric goal calculation results in improvement in muscular structure, and consequent reduction of mechanical ventilation duration in patients with sepsis in comparison to utilizing the Penn State estimation equation for caloric goal calculation. The secondary objective is to assess whether the utilization of indirect calorimetry for caloric goal calculation results in improved adequacy of nutritional delivery in comparison to the adequacy of nutritional delivered when utilizing the Penn State estimation equation. Adult patients (\> 18 years of age) admitted to the hospital with diagnosis of sepsis, and who require mechanical ventilation during hospitalization will be considered. Patients newly ventilated for at least one day but less than three days will be included in the study. Informed consent will be obtained from the legal authorized representative (LAR).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable sepsis
Started Sep 2018
Shorter than P25 for not_applicable sepsis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 17, 2018
CompletedFirst Posted
Study publicly available on registry
February 22, 2018
CompletedStudy Start
First participant enrolled
September 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 3, 2019
CompletedOctober 22, 2020
January 1, 2019
9 months
January 17, 2018
October 21, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ventilator free days (VFD)
The number of days from day 1 to day 28 (of hospital admission) on which the patient was not on the mechanical ventilator. If the patient expired or requires more than 28 days of mechanical ventilation, the value is zero.
From current hospital admission date until the date of hospital discharge, date of death from any cause, whichever came first, assessed up to 28 days.
Secondary Outcomes (3)
Calorie and protein adequacy
Nutritional adequacy will be assessed from day one of ventilation in all patients until extubation from the MV or date of death, whichever came first, assessed up to 14 days.
Change in quadricep muscle thickness
Quadricep muscle thickness will be measured upon enrollment to the study (within 72 hours of MV) and every 3-5 days with a minimum of two times per 7 days until extubation from the MV or date of death, whichever came first, assessed up to 14 days.
Change in diaphragm muscle thickness
Diaphragm muscle thickness will be measured upon enrollment to the study (within 72 hours of MV) and then every 3-5 days with a minimum of two times per 7 days until extubation from the MV or date of death, whichever came first, assessed up to 14 days.
Other Outcomes (3)
Hospital Mortality
From current hospital admission date until the date of hospital discharge or date of death from any cause, whichever came first, assessed up to 24 months.
Hospital length of stay
From current hospital admission date until the date of hospital discharge or date of death from any cause, whichever came first, assessed up to 24 months.
Intensive care unit length of stay
From current hospital admission date until the date of hospital discharge or date of death from any cause, whichever came first, assessed up to 24 months.
Study Arms (2)
Measured Arm
EXPERIMENTALPatients allocated to the measured energy expenditure (group M) will receive the intervention. Caloric delivery will target results of IC measurement.
Estimated Arm
NO INTERVENTIONPatients allocated to the estimated energy expenditure (group E) will receive nutrition with caloric intake calculated based on the Penn State equation.
Interventions
The prescribed calories to be delivered will be set to target the measurement obtained from performing indirect calorimetry (IC). IC measures the gas exchange of oxygen consumption and carbon dioxide production to determine the true metabolic needs for cellular respiration. The expenditure of calories will be measured utilizing the gas module incorporated within the General Electric Carescape R860 ventilators.
Eligibility Criteria
You may qualify if:
- New Medical ICU admits
- Mechanically ventilated for one day and less than 3 days upon enrollment
- Adults 18 years or older
- Expected length of ICU stay greater than 3 days
- Initiated on nutrition support (parenteral/or enteral nutrition)
- Sepsis diagnosis documented by physician within one day of ICU admit
- Signed informed consent
You may not qualify if:
- Does not meet all criteria of valid indirect calorimetry test for baseline -measurement
- Receiving pulmonary inhaled vasodilator
- Extracorporeal Membrane, Oxygenation (ECMO)
- Pregnancy
- Patients required to be in prone position
- Reintubation
- DNR/AND
- Prisoner
- Employee of BSWH
- Students in contractual agreement with BSWH entity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Baylor University Medical Center
Dallas, Texas, 75246, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ashley Mullins, MS
Baylor Health Care System
- PRINCIPAL INVESTIGATOR
Ariel Modrykamien, MD
Baylor Health Care System
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 17, 2018
First Posted
February 22, 2018
Study Start
September 10, 2018
Primary Completion
May 31, 2019
Study Completion
October 3, 2019
Last Updated
October 22, 2020
Record last verified: 2019-01
Data Sharing
- IPD Sharing
- Will not share